Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. (Q50705457)
Jump to navigation
Jump to search
scientific article published in February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. |
scientific article published in February 2007 |
Statements
Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. (English)
1 reference
David H Henry
1 reference
Naomi V Dahl
1 reference
Michael Auerbach
1 reference
Simon Tchekmedyian
1 reference
Leslie R Laufman
1 reference
1 February 2007
1 reference
12
1 reference
2
1 reference
231-242
1 reference
Identifiers
1 reference